Pfizer has entered into an oncology collaboration with Nektar Therapeutics, a US development stage biopharma company.
Germany’s Federal Patent Court has published the reasoning behind its decision to revoke Gilead Sciences’ supplementary protection certificate for HIV/AIDS treatment Truvada,
Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report.
HGF has strengthened its Basel, Switzerland office with the addition of Leena Contarino as a partner.
A US district court has ordered Australia-based Cochlear to pay $268 million in damages to the Alfred E Mann Foundation for Scientific Research and Advanced Bionics.
Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences for $1.2 billion.
California-based Gilead Sciences has signed a collaboration agreement with Tango Therapeutics to discover and develop a pipeline of immuno-oncology treatments for cancer patients.
Alex Tse, US attorney for the Northern District of California, has charged three former Genentech employees with trade secrets theft.
The company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, ERS Genomics, has signed a patent licensing deal with DefiniGEN, a spin-out from the University of Cambridge, UK.
Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.